Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin
Authors:
Open Access
- 20 May 2010
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 219
Abstract
The opposite effects of chemotherapy, which enhance the malignancy of treated cancers such as hepatocellular carcinoma (HCC), are not well understood. We investigated this phenomenon and corresponding mechanisms to develop a novel approach for improving chemotherapy efficacy in HCC.Keywords
This publication has 29 references indexed in Scilit:
- Reduced proliferation and enhanced migration: Two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1Cell Cycle, 2009
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProceedings of the National Academy of Sciences, 2009
- Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancersDrug Resistance Updates, 2008
- Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cellsInternational Journal of Oncology, 2007
- Strategies for the management of hepatocellular carcinomaNature Clinical Practice Oncology, 2007
- Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After ResectionJournal of Clinical Oncology, 2007
- Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell LinesClinical Cancer Research, 2006
- JS‐K, a novel non‐ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c‐Jun phosphorylation via multiple MAP kinase pathwaysJournal of Cellular Physiology, 2003
- Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97World Journal of Gastroenterology, 2001
- PROMOTION OF PULMONARY METASTASIS IN MICE BY BLEOMYCIN-INDUCED ENDOTHELIAL INJURY1986